Jazz Argues Drug Patent Should Stay In Orange Book
By Kelly Lienhard · February 14, 2023, 9:43 PM EST
Jazz Pharmaceuticals tried to convince the Federal Circuit in oral arguments on Tuesday to overturn a lower court order to remove its patent for its narcolepsy drug from the Food and Drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login